Short interest in Protalix BioTherapeutics Inc (AMEX:PLX) decreased during the last reporting period, falling from 3.27M to 3.13M. This put 4.45% of the company's publicly available shares short.

Short interest for Protalix BioTherapeutics gives investors a sense of the degree to which investors are betting on the decline of Protalix BioTherapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 137.23K shares traded per day, it would take 22.78 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.